Levetiracetam
Rank #165 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$96.1M
Total Cost
1,723,736
Total Claims
$96.1M
Total Cost
35,923
Prescribers
$56
Cost per Claim
222,423
Beneficiaries
2,613,320
30-Day Fills
$2,676
Avg Cost/Provider
48
Avg Claims/Provider
Share of Medicare Part D Spending
0.03%
of total Medicare Part D spending
$96.1M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $96.1M total
Top Prescribers of Levetiracetam
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Ignacio Pita Garcia | Neurology | Guaynabo, PR | 319 | $486K |
| 2 | Deborah Zielinski | Nurse Practitioner | Chicago, IL | 103 | $313K |
| 3 | David Ficker | Neurology | Cincinnati, OH | 149 | $308K |
| 4 | Jessica Locke | Nurse Practitioner | Gainesville, FL | 139 | $297K |
| 5 | Andrew Blum | Neurology | Providence, RI | 97 | $266K |
| 6 | Myriam Abdennadher | Neurology | Boston, MA | 110 | $234K |
| 7 | Deborah Combs Cantrell | Neurology | Lewisville, TX | 90 | $214K |
| 8 | Stephan Eisenschenk | Neurology | Gainesville, FL | 74 | $184K |
| 9 | James Tao | Neurology | Chicago, IL | 91 | $181K |
| 10 | Scott Scheuermann | Nurse Practitioner | Gainesville, FL | 80 | $172K |
| 11 | Louann Carnahan | Neurology | Tucson, AZ | 80 | $158K |
| 12 | Christi Ledo | Nurse Practitioner | Kansas City, MO | 57 | $151K |
| 13 | Bethany Thomas | Nurse Practitioner | Philadelphia, PA | 47 | $151K |
| 14 | Ignacio Pita Garcia | Neurology | Guaynabo, PR | 83 | $146K |
| 15 | Tracy Jasinski | Nurse Practitioner | Omaha, NE | 47 | $143K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 162 | Dexlansoprazole (Dexlansoprazole Dr) | $98.7M | 275,116 |
| 163 | Interferon Beta-1a (Avonex) | $98.3M | 11,314 |
| 164 | Guselkumab (Tremfya) | $97.1M | 7,102 |
| 165 | Levetiracetam (Levetiracetam) | $96.1M | 1,723,736 |
| 166 | Oxycodone Myristate (Xtampza Er) | $96.1M | 141,266 |
| 167 | Sevelamer Carbonate (Sevelamer Carbonate) | $95.6M | 277,192 |
| 168 | Aripiprazole Lauroxil (Aristada) | $93.3M | 31,120 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology